drugset / Trial / NCT02087865

Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease

NCT02087865

RandomizedParallel-groupTriple-blindOther

Summary

This study examines the sensitivity of functional MRI to detect brain changes caused by donepezil HCL (a cholinesterase inhibitor) in healthy older adults at genetic risk for Alzheimer's Disease.

Timeline

Start
2014-05
Primary completion
2021-12-20
Completion
2021-12-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Donepezil Small molecule 10 mg